142 related articles for article (PubMed ID: 7547638)
21. Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma.
Katsama A; Sourvinos G; Zachos G; Spandidos DA
Cancer Lett; 2000 Mar; 150(2):165-70. PubMed ID: 10704738
[TBL] [Abstract][Full Text] [Related]
22. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer.
Latil A; Bièche I; Pesche S; Volant A; Valèri A; Fournier G; Cussenot O; Lidereau R
Hum Pathol; 1999 Jul; 30(7):809-15. PubMed ID: 10414500
[TBL] [Abstract][Full Text] [Related]
24. Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues.
Mutirangura A; Charuruks N; Shuangshoti S; Sakdikul S; Chatsantikul R; Pornthanakasem W; Sriuranpong V; Supiyaphun P; Voravud N
Int J Cancer; 1999 Oct; 83(2):210-4. PubMed ID: 10471529
[TBL] [Abstract][Full Text] [Related]
25. Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas.
Tsukamoto K; Ito N; Yoshimoto M; Iwase T; Tada T; Kasumi F; Nakamura Y; Emi M
Cancer; 1996 Nov; 78(9):1929-34. PubMed ID: 8909313
[TBL] [Abstract][Full Text] [Related]
26. Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma.
Tsang YS; Lo KW; Leung SF; Choi PH; Fong Y; Lee JC; Huang DP
Int J Cancer; 1999 Oct; 83(3):305-8. PubMed ID: 10495420
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
[TBL] [Abstract][Full Text] [Related]
28. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA
Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992
[TBL] [Abstract][Full Text] [Related]
29. Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia.
Garcia-Marco JA; Caldas C; Price CM; Wiedemann LM; Ashworth A; Catovsky D
Blood; 1996 Sep; 88(5):1568-75. PubMed ID: 8781411
[TBL] [Abstract][Full Text] [Related]
30. Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer.
Kwiatkowska E; Teresiak M; Breborowicz D; Mackiewicz A
Int J Cancer; 2002 Apr; 98(6):943-5. PubMed ID: 11948477
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors.
Tong D; Kucera E; Schuster E; Schmutzler RK; Swoboda H; Reinthaller A; Leodolter S; Zeillinger R
Int J Cancer; 2000 Oct; 88(2):319-22. PubMed ID: 11004687
[No Abstract] [Full Text] [Related]
32. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q.
Kuroki T; Fujiwara Y; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
Br J Cancer; 1995 Aug; 72(2):383-5. PubMed ID: 7640222
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.
Kerangueven F; Eisinger F; Noguchi T; Allione F; Wargniez V; Eng C; Padberg G; Theillet C; Jacquemier J; Longy M; Sobol H; Birnbaum D
Oncogene; 1997 Jan; 14(3):339-47. PubMed ID: 9018120
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
[TBL] [Abstract][Full Text] [Related]
35. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
36. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer.
Tamura K; Zhang X; Murakami Y; Hirohashi S; Xu HJ; Hu SX; Benedict WF; Sekiya T
Int J Cancer; 1997 Feb; 74(1):45-9. PubMed ID: 9036868
[TBL] [Abstract][Full Text] [Related]
37. Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.
Grimmond SM; Palmer JM; Walters MK; Scott C; Nancarrow DJ; Teh BT; Elmes C; Pyke C; Khoo SK; Bennett I; Wetzig N; Hayward NK
Hum Genet; 1996 Jul; 98(1):80-5. PubMed ID: 8682513
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
Rio PG; Pernin D; Bay JO; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon DJ; Bignon YJ
Int J Oncol; 1998 Oct; 13(4):849-53. PubMed ID: 9735416
[TBL] [Abstract][Full Text] [Related]
39. Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance.
Chung CY; Kantarjian H; Haidar M; Starostik P; Manshouri T; Gidel C; Freireich E; Keating M; Albitar M
Cancer; 2000 Mar; 88(6):1359-64. PubMed ID: 10717617
[TBL] [Abstract][Full Text] [Related]
40. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma.
Kirkpatrick H; Waber P; Hoa-Thai T; Barnes R; Osborne-Lawrence S; Truelson J; Nisen P; Bowcock A
Oncogene; 1997 May; 14(18):2189-93. PubMed ID: 9174054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
